youtube_live
Q3 2026 earnings • released • EPS miss -81.97% • Revenue miss -0.27%
See resultschevron_right
HIMS:NYSE
Hims & Hers Health Inc
$19.51
arrow_upward
+1.99%(+0.38) 1D
Nov 11, 10:05:07 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HIMS...
Open
$19.27
High
$19.99
Low
$19.05
Mkt. cap
4.57B
Avg. vol.
13.29M
Volume
3.56M
52-wk high
$40.99
52-wk low
$13.74
EPS
-$0.63
Beta
2.53
Shares outstanding
224.94M
No. of employees
2K
Open
$19.27
High
$19.99
Low
$19.05
Mkt. cap
4.57B
Avg. vol.
13.29M
Volume
3.56M
52-wk high
$40.99
52-wk low
$13.74
EPS
-$0.63
Beta
2.53
Shares outstanding
224.94M
No. of employees
2K
News stories
From web sources and news partners
Benzinga
·
51 minutes ago
Hims & Hers Week in Review: Q3 Miss, Weak Q4 Outlook, Huberman Joins Board
TradingView
·
2 hours ago
Hims & Hers Faces A ‘Transition Year’ Amid Increasing AI Investments, Says KeyBanc – Expects Lower Pricing To Weigh On FY2027-2028 Earnings Outlook
Investing.com
·
4 hours ago
Hims and Hers stock rating held at Sector Weight by KeyBanc
BigGo Finance
·
5 hours ago
Hims & Hers Hit With Five-State FTC Privacy Suit After Stock's Worst Day Since 2025
Profile
Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model. Wikipedia
About Hims & Hers Health Inc
CEO-
Employees2.44K
FoundedNov 2017
HeadquartersSan Francisco, California, United States
SectorHealth Care
IndustryHealth care provider
Website-